Reuters: Merck moves into emerging markets and generic biotech

[chris]

Merck moves into emerging markets and generic biotech
      

NEW YORK (Reuters) - Merck &amp; Co  said on Tuesday it plans to break into biologics, including generic biotech medicines, and push into emerging markets as it confronts near and long-term challenges to key medicines.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login